Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2016 Sep 13;11(9):e0162611. doi: 10.1371/journal.pone.0162611

Metabolic Risk Factors of Type 2 Diabetes Mellitus and Correlated Glycemic Control/Complications: A Cross-Sectional Study between Rural and Urban Uygur Residents in Xinjiang Uygur Autonomous Region

Guo-li Du 1,#, Yin-xia Su 2,#, Hua Yao 2,*, Jun Zhu 1, Qi Ma 2, Ablikm Tuerdi 1, Xiao-dong He 1, Li Wang 2, Zhi-qiang Wang 3, Shan Xiao 1, Shu-xia Wang 4, Li-ping Su 5
Editor: Cheng Hu6
PMCID: PMC5021360  PMID: 27622506

Abstract

Background

Diabetes is a major global public health problem driven by a high prevalence of metabolic risk factors.

Objective

To describe the differences of metabolic risk factors of type 2 diabetes, as well as glycemic control and complicated diabetic complications between rural and urban Uygur residents in Xinjiang Uygur Autonomous Region of China.

Methods

This comparative cross-sectional study, conducted among 2879 urban and 918 rural participants in Xinjiang, China, assessed the metabolic risk factors of diabetes and related complications differences between urban and rural settlements.

Results

Compared to rural areas, urban participants had higher education level and more average income, little physical activity, less triglycerides and higher HDL-c (p < 0.05 respectively). Differences in metabolic risk factors by urban/rural residence included overweight or obesity, triglycerides (≥1.71mmol/l), HDL-c (< 1.04 mmol/l), alcohol intake, and physical inactivity (p < 0.01 respectively). There was significant difference regarding the prevalence of HbA1c >8% (48.1% versus 54.5%, p = 0.019) between rural and urban diabetic participants. No significant difference in the prevalence of type 2 diabetic complications between urban and rural participants (74.9% versus 72.2%; p = 0.263) was detected. Compared to rural participants, the most prevalent modifiable risk factors associated with diabetic complications in urban participants were obesity (BMI ≥ 28 Kg/m2), HDL-c (< 1.04 mmol/l), physical inactivity and irregular eating habits (p = 0.035, p = 0.001, p < 0.001, and p = 0.013, respectively).

Conclusions

Urban settlers were significantly more likely to have metabolic risk factors highlighting the need for public health efforts to improve health outcomes for these vulnerable populations. Diabetes related complications risk factors were prevalent amongst rural and urban diabetes settlers.

Introduction

Type 2 diabetes mellitus (T2DM), as the fourth major cause of mortality worldwide, is a major public health problem presenting a significant rising prevalence [1,2]. It is a complex metabolic disease mostly resulting from the interaction among genetic, environmental and other risk factors. Risk factors for T2DM include obesity [3], sedentary lifestyle [4], smoking [5], high fat/cholesterol diet [6] and refined carbohydrates [7], and some psychological factors [1,3]. This metabolic disease requires effective long-term management to achieve optimal glycemic control and minimize chronic complications [810].

In developing countries, with rapid western cultural adaptation and urbanization [9,11], diabetes prevalence is rising dramatically [12], accompanied with the rising burden of this condition [1316]. In China, it was reported that the prevalence of T2DM among people older than 20-year-old was 9.7% and more common in the capital city [1719]. For example, an isolated study reported that the prevalence of T2DM had been increasing sharply and the prevalence of diabetes increased from 9.7% to 12.6% between 2002 and 2009 in Shanghai, the largest city of China with rapid urbanization [20].

Previous study showed that the prevalence of diabetes was higher in urban population than rural population [4,6,21], and a higher prevalence [22] increased in rural communities [12,23]. Diabetes affects 14.1% people living in urban areas in China [20]. Urban populations often live with better socioeconomic conditions, higher level of education and less physical activity compared with rural populations [24].

Bordering eight countries including Russia, Kazakhstan, Kyrgyzstan, Tajikistan, Pakistan, Mongolia, India, and Afghanistan, Xinjiang Uygur Autonomous Region is located in the northwest of China and composed of more than 13 ethnic groups, with Uygur accounting for 46%, Han accounting for 40%, and Kazak accounting for 7%. Originating from inter-marriage between Caucasians and Mongolians, the Uygur people have their own language, culture, genetic background, lifestyle, and dietary habits. Previous reports showed differences between Uygur and Han regarding the prevalence of T2DM [25] and genetic polymorphism [26,27]. The current study sought to assess the differences in prevalence of T2DM and metabolic risk factors among general and diabetic populations and their variations across compared populations in Xinjiang, China, drawn from urban and rural Uygur settlements.

Materials and Methods

Study population

This comparative cross-sectional study was conducted among 2897 urban and 918 rural participants ≥ 20 years of age, both located in Xinjiang Uygur Autonomous Region (Kashgar and Urumqi), from March 2012 to December 2013.

Participants were enrolled in the current study via simple random sampling technique. A representative sample of the general populations of Uygur were chosen and classified as urban and rural groups based on the government record of registered residence, settlement, location and way of life of the people [28].

Pregnant women, individuals with type 1 diabetes, MODY, stress hyperglycemia, malignant tumor, autoimmune disease, physically or mentally disabled persons and those with incomplete data were excluded.

Anthropometric measurements

An interview-based questionnaire was used to gather information on socio-demographic and metabolic risk factors. It was designed in the Chinese language but translated into Uygur language for those who didn’t understand Chinese. The questionnaire collected information including demographic and socioeconomic status and medical history.

Family monthly income was used to evaluate household socioeconomic status. Food consumption over the past 7 days was calculated to analyze the eating habits.

Body weight, height, waist circumference and blood pressure measurements were performed using standardized methods. Body weight was measured to the nearest 0.1 Kg in light clothing with a mechanical scale. Height was measured to the nearest 0.1 cm without shoes, with a commercial stadiometer (HW-900B OMRON, Japan).

With the subjects standing and breathing normally, using a measuring tape parallel to the floor, waist circumference (WC) was measured at midpoint between the last palpable rib and the suprailiac crest, and the hip circumference (HC) was measured at the outermost points of the greater trochanters [6,29]. The formula; weight (Kg) / height (m2) was used to calculate the body mass index (BMI), WC (cm) / HC (cm) was used to calculate waist-to-hip ratio (WHR), and WC (cm) / height (cm) was used to calculate the waist-to-height ratio (WHtR).

Blood pressure was measured three times with a 5 minutes interval, by tail cuff method on the upper left arm with the patient in sitting position and after at least 5 minutes of rest [30]. The mean value of the last two measurement was used for analysis. Hypertension was defined as systolic pressure (SBP) ≥ 140 mmHg and/or diastolic pressure (DBP) ≥ 90 mmHg or self-reported use of antihypertensive medications irrespective of measured blood pressure.

Occupation

Occupational data gathered were classified as formal, informal and unemployed based on set criteria. Those jobs with normal hours, regular wages recognized as income sources on which income taxes must be paid were considered as “formal” jobs. “Informal” jobs were defined as any such contrary to this.

Biochemical assays

After observing an overnight fast (12–14 hours), blood specimen was collected for biochemical measurements. For each subject with no history of T2DM, an oral glucose tolerance test was taken, using a glucose load containing the equivalent of 75 g anhydrous glucose dissolved in water. T2DM was diagnosed according to measured glucose levels by WHO 1999 criteria [31], with a fasting plasma glucose (FPG) level ≥ 7.0 mmol/l after a minimum overnight 12 h fast, or a 2 h post-glucose level ≥ 11.1 mmol/l during an OGTT with symptoms of diabetes. In the absence of classic symptoms of hyperglycemia, results should be confirmed by repeating test in another day.

Blood glucose, as well as, glycosylated hemoglobin (HbA1c), total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-c) and low-density lipoprotein cholesterol (LDL-c) were measured using the Dimension AR/AVL Clinical Chemistry System (Newark, NJ, USA) in the central laboratory of the First Affiliated Hospital of Xinjiang Medical University. Hyperlipidemia was defined based on lipids levels with TG ≥ 1.71mmol/l or/and LDL-c ≥ 3.38 mmol/l, or/and TC ≥ 5.20 mmol/l.

Determination of T2DM related complications

CHD was identified from the linked data set using all diagnosis fields, and the presence of CHD was determined by an expert cardiologist [32,33]. Cerebrovascular disease was evaluated and determined by the specialist in Neurological department [19]. Screening for peripheral arterial disease (PAD) including a history for claudication and an assessment of the pedal pulses (the ankle-brachial index, ABI) was performed before the diagnosis [34,35]. Retinal vascular changes were evaluated with a dilated fundus examination followed by fundus fluorescein angiography (FFA), and those allergic to contrast agent would be evaluated by fundus photography. The diagnosis of diabetic peripheral neuropathy was based on the medical history and simple clinical tests including 10-g monofilament testing and at least one of the following tests: pinprick, temperature, or vibration sensation. Electrophysiological testing or referral to a neurologist was advised in situations where the clinical features were atypical or the diagnosis was unclear [1]. The diagnosis of diabetic nephropathy was based on urine albumin excretion, serum creatinine and estimated GFR [36,37].

Statistical methods

Statistical was analyzed using SPSS16.0. Most of the variables were analyzed through descriptive statistics (Median (IQR) and percentage). Categorical variables were compared using the Chi-square or Fisher’s test. Multivariate logistic regression model was built to analyze the association of metabolic risk factors with urban residence, adjusted for age and gender. The associations between various variables within each population group was determined using Spearman’s rho (Rank) correlation analysis. It was considered statistically significant as p < 0.05.

Ethical consideration

The study was conducted in accordance with the Declaration of Helsinki guidelines and approved by the Ethics Committee of the First Affiliated Hospital of Xinjiang Medical University. Participation was voluntary and written informed consent was obtained from the participants.

Results

Population characteristics

The socio-demographic characteristics of the study populations are shown in Table 1. There were significant differences between urban and rural participants with respect to gender distribution (p < 0.001) and mean age (p < 0.001). The participants in the urban area lived with higher average income, compared to that observed amongst participants in the rural area (p < 0.001). There were statistically significant differences in the marital status (p = 0.004), employment (p < 0.001), education (p < 0.001), physical activity on regular basis (p < 0.001) and alcohol intake (p < 0.001). No significant differences regarding intensity of performed physical activity, eating habits, reached recommended amount of fruits and vegetables/day and smoking were found between urban and rural participants (p = 0.840, 0.309, 0.411 and 0.961 respectively).

Table 1. Socio-demographic characteristics of the population.

Variables Total (n = 3797) Rural (n = 918) Urban (n = 2879) p-value
Age (years)
Median (IQR) 46.0 (38.0–55.0) 49.0 (40.0–58.0) 44.7 (37.3–53.2) < 0.001
20–29 yrs n (%) 317 (8.3) 69 (7.5) 248 (8.6)
30–39 yrs n (%) 867 (22.8) 152 (16.6) 715 (24.8)
40–49 yrs n (%) 1182 (31.1) 248 (27.0) 934 (32.4)
50–59 yrs n (%) 847 (22.3) 253 (27.6) 594 (20.6)
60+ yrs n (%) 584 (15.4) 196 (21.4) 388 (13.5) < 0.001
Gender n (%)
Male 2166 (57.0) 573 (62.4) 1593 (55.3)
Female 1631 (43.0) 345 (37.6) 1268 (44.7) < 0.001
Family history of diabetes n (%)
No 2942 (77.5) 733 (79.8) 2209 (76.7)
Yes 855 (22.5) 185 (20.2) 670 (23.3) 0.049
Marital status n (%)
Single 238 (6.3) 40 (4.4) 198 (6.9)
Married 3487 (91.9) 852 (92.8) 2635 (91.6)
Divorced 31 (0.8) 12 (1.3) 19 (0.7)
Widowed 40 (1.1) 14 (1.5) 26 (0.9) 0.004
Occupation n (%)
Formal 2585 (68.2) 488 (49.0) 2137 (74.3)
Informal 466 (12.3) 228 (24.9) 238 (8.3)
Unemployed 740 (19.5) 238 (26.0) 502 (17.4) < 0.001
Level of education n (%)
Illiterate 78 (2.1) 51 (5.6) 27 (0.9)
Basic 294 (7.8) 156 (17.1) 138 (4.8)
Secondary education 1411 (37.2) 440 (48.1) 971 (33.8)
Tertiary 2007 (53.0) 267 (29.2) 1740 (60.5) < 0.001
Average income (RMB) n (%)
<2000 733 (19.3) 321 (35.1) 412 (14.3)
2000~4000 1398 (63.2) 519 (56.8) 1879 (65.3)
4000~6000 562 (14.8) 60 (6.6) 502 (17.4)
6000~8000 72 (1.9) 11 (1.2) 61 (2.1)
≥8000 27 (0.7) 3 (0.3) 24 (0.8) < 0.001
Smoking n (%)
No 2598 (68.9) 631 (68.8) 1967 (68.9)
Yes 1174 (31.1) 286 (31.2) 888 (31.1) 0.961
Alcohol intake n (%)
No 2877 (76.8) 740 (81.6) 2137 (75.3)
Yes 868 (23.2) 167 (18.4) 701 (24.7) < 0.001
Physical activity on regular basis
No 2273 (59.9) 310 (33.8) 1214 (42.2)
Yes 1524 (40.1) 608 (66.2) 1665 (57.8) < 0.001
Intensity of performed physical activity
High 114 (7.5) 21 (6.8) 93 (7.7)
Moderate 77 (5.1) 15 (4.8) 62 (5.1)
Low 1330 (84.7) 274 (88.4) 1056 (87.2) 0.840
Eating habits
3 main courses/day 3143 (82.9) 771 (84.0) 2372 (82.5)
Irregular habits 649 (17.1) 147 (16.0) 502 (17.5) 0.309
Reached recommended amount of fruits and vegetables/day
No 705 (19.1) 182 (20.0) 523 (18.8)
Yes 2992 (80.9) 728 (80.0) 2264 (81.2) 0.411

Data is presented as median (IQR) or n(%); Chi-square or Fisher’s test. p < 0.05 was considered significant difference. n: number. Line45: Only participants reporting regular physical activity included in this analysis, ≥ 5 times/week at moderate or high intensity, Line 55: 500 grams of fruits and vegetables/day.

Metabolic risk factors in urban and rural population

Among participants, systolic and diastolic BP median (IQR) was 121(111–130) and 83(70–90) mmHg, respectively, and rural participants had higher blood pressure compared to urban participants. As shown in Table 2, regarding hip circumference and WHR, participants in the urban area had significantly higher measures (p < 0.001 respectively). There were no significant differences in BMI between urban and rural people (p = 0.229). Participants in the rural area had significantly higher levels of serum triglyceride levels than those participants in the urban area (p < 0.001). For HDL-c, the urban participants were higher than rural participants (p < 0.001) [Table 2].

Table 2. Anthropometric variables and serum lipid levels of the study population, median (IQR) or n (%).

Variables Total (n = 3797) Rural (n = 918) Urban (n = 2879) p-value
FBS 5.39 (4.72–7.81) 6.61 (5.01–9.25) 5.21 (4.67–7.33) < 0.001
Type 2 Diabetes 1507(39.7) 513(55.9) 994(34.5) < 0.001
Pre-diabetes 924(24.3) 340(37.0) 584(20.3) < 0.001
Hypertention 1317(34.7) 397(43.4) 920(32.0) < 0.001
SBP (mmHg) 122 (111–130) 124 (115–130) 121 (110–130) < 0.001
DBP (mmHg) 83 (70–90) 85 (72–92.5) 82 (70–90) < 0.001
Weight (Kg) 76(67–84) 75(66–84) 76.5 (68–83.5) 0.239
Height (cm) 168(163–172) 168(162–173) 168 (163–172) 0.922
BMI (Kg/m2) 26.47 (24.27–29.05) 26.44 (23.99–29.29) 26.53 (24.39–29.03) 0.229
Obesity (BMI ≥ 28 Kg/m2) 1283(33.9) 311(33.9) 972(33.8) 0.985
WC 95.0 (88.5–102) 96 (88–104) 95 (88.5–102.0) 0.067
HC 100.0 (85.0–108.0) 102 (93–110) 103.00 (95–109.00) < 0.001
WHR 0.94 (0.89–1.07) 0.93 (0.89–1.01) 0.95 (0.88–1.11) < 0.001
Hperlipidemia 2957(77.0) 780(85.0) 2177(75.6) < 0.001
TC (mmol/l) 4.31 (2.95–5.12) 4.2 (2.76–5.05) 4.34 (3.04–5.15) 0.078
TG (mmol/l) 1.93 (1.17–4.03) 2.05 (1.27–4.13) 1.85 (1.13–3.94) < 0.001
HDL-c (mmol/l) 1.12 (0.92–1.34) 1.03 (0.83–1.26) 1.15 (0.95–1.36 < 0.001
LDL-c (mmol/l) 2.77 (2.31–3.32) 2.78 (2.26–3.32) 2.77 (2.33–3.32) 0.705

Data is presented as median (IQR) or n (%); Chi-square or Fisher’s test. p < 0.05 was considered significant difference. IQR: Interquartile range, BMI: Body Mass Index, WC: Waist Circumference, HC: Hip Circumference, WHR: Waist to Hip Ratio, TC: Total Cholesterol, TG: Triglycerides, HDL-c: High Density Lipoprotein cholesterol, LDL-c: Low Density Lipoprotein cholesterol.

In Table 3, metabolic risk factors between rural and urban participants were compared. The prevalence of hypertension was 43.4% in rural residents, higher than that in urban residents (32.0%, p < 0.001). The prevalence of overweight (BMI ≥ 25 Kg/m2) and obesity (BMI ≥ 28 Kg/m2) were greater in urban participants than that in rural participants (p < 0.001 and p < 0.001 respectively). For hyperlipidaemia, the prevalence of higher triglyceride (≥ 1.71 mmol/l) and less HDL cholesterol (< 1.04 mmol/l) were observed higher among rural participants (p = 0.002 and p < 0.001 respectively). There were no differences between rural and urban residents regarding TC ≥ 5.20 mmol/l (21.8% versus 23.6%, p = 0.265) and LDL-c ≥ 3.38 mmol/l (23.1% versus 23.3%, p = 0.920). In contrast, participants in the urban area were more likely than rural residents, to have more alcohol intake, as well as less physical inactivity (p < 0.001 and p = 0.002 respectively).

Table 3. Metabolic risk factors in urban population compared with rural population.

Risk factors Crude OR (95% CI) Total (n = 3797) n (%) Rural (n = 918) n (%) Urban (n = 2879) n (%) p-value
Hypertension 0.613 (0.527–0.715) 1317 (34.8) 397 (43.4) 920 (32.0) <0.001
BMI(≥ 25 Kg/m2) 2.637 (2.097–3.317) 2128 (84.9) 450 (74.1) 1678 (88.3) <0.001
BMI (≥ 28 Kg/m2) 2.210 (1.737–2.813) 1283 (77.2) 311 (66.5) 972 (81.4) <0.001
WC (men ≥ 90 cm; women ≥ 85 cm) 1.039 (0.868–1.243) 2972 (78.4) 715 (77.9) 2257 (78.5) 0.679
WHR (men > 0.90; women > 0.85) 0.813 (0.676–0.977) 2944 (77.6) 737 (80.3) 2207 (76.8) 0.027
TC (≥ 5.20 mmol/l) 1.107 (0.926–1.324) 879 (23.2) 200 (21.8) 679 (23.6) 0.265
LDL-c (≥3.38 mmol/l) 1.009 (0.846–1.204) 882 (23.2) 212 (23.1) 670 (23.3) 0.920
HDL-c (< 1.04 mmol/l) 0.517 (0.445–0.601) 1472 (38.8) 467 (31.7) 1005 (34.9) <0.001
TG (≥ 1.71mmol/l) 0.785 (0.675–0.913) 2097 (55.3) 548 (59.8) 1549 (53.8) 0.002
Alcohol intake 1.454 (1.204–1.755) 868 (23.2) 167 (18.4) 701 (24.7) <0.001
Smoking 0.996 (0.848–1.170) 1174 (31.1) 286 (31.2) 888 (31.1) 0.961
Physical inactivity 0.699 (0.599–0.817) 2273 (59.9) 608 (66.2) 1665 (57.8) <0.001
Irregular eating habits 0.110 (0.908–1.357) 649 (17.1) 147 (16.0) 502 (17.5) 0.309

Data is presented as n (%); OR: Odds ratio. Compared using multivariate logistic regression. p < 0.05 was considered significant difference. BMI: Body Mass Index, WC: Waist Circumference, WHR: Waist to Hip Ratio, TC: Total Cholesterol, LDL-c: Low Density Lipoprotein cholesterol, HDL-c: High Density Lipoprotein cholesterol, TG: Triglycerides.

In Table 4, SBP correlated positively with DBP and so was waist circumference with WHR, WHtR, total cholesterol, LDL-c and HDL-c in participants of both urban and rural areas. A significant positive correlation between DBP and BMI was observed only in the urban participants. There were also significant positive correlations between BMI and WC, WHR, total cholesterol, triglycerides, LDL-c and HDL-c both in rural and urban participants and so was total cholesterol with triglycerides and LDL-c. LDL-c showed a significant positive association with FBS and HbA1c in urban participants but not in rural participants. FBS showed a significant positive association with HC amongst participants only in urban participants.

Table 4. Spearman’s rho correlation coefficients between selected metabolic variables for rural (Lower Left-Hand Side) and urban (Upper Right-Hand Side).

Variables SBP DBP FBS HbA1c BMI WC HC WHR WHtR TC
SBP 1 0.416** 0.206** -0.058 0.189 ** 0.123** 0.212 ** -0.050** 0.132** 0.096**
DBP 0.306 ** 1 0.012 -0.103** 0.075** -0.049** 0.293** -0.278** -0.040* -0.345**
FBS 0.221 ** -0.204** 1 0.506 ** 0.178** 0.239 ** 0.250 ** 0.049** 0.216** 0.173**
HbA1c -0.037 -0.153** 0.508** 1 -0.107 **H7 -0.032 -0.013 0.001 -0.007 0.100*
BMI 0.141 ** 0.011 0.086* 0.014 1 0.558 ** 0.202** 0.234** 0.580** 0.108**
WC 0.092 ** -0.075* 0.141** -0.026 0.607 ** 1 0.289 ** 0.445** 0.926** 0.179**
HC 0.068 * 0.083* 0.059 0.013 0.436 ** 0.624 ** 1 -0.629** 0.280** -0.131**
WHR 0.087 ** -0.181** 0.185** -0.051 0.200 ** 0.408 ** -0.318** 1 0.404** 0.290**
WHtR 0.104** -0.085** 0.140** -0.002 0.619 ** 0.937 ** 0.573 ** 0.397** 1 0.174**
TC 0.224 ** -0.283** 0.315** 0.082 0.112 ** 0.145 ** -0.042 0.262** 0.152** 1
TG -0.066* 0.393 ** -0.168** 0.032 0.114 ** 0.055 0.155** -0.103** 0.048 -0.220**
LDL-c 0.083* 0.151 ** -0.013 0.06 0.089** 0.088 ** 0.072* 0.043 0.088** 0.495**
HDL-c -0.133** 0.182 ** -0.482** 0.021 -0.150 ** -0.175 ** -0.090** -0.186** -0.154** -0.061
EH 0.024 -0.048 0.115 ** 0.133* 0.025 0.042 0.012 0.091** 0.03 0.077*
EDU -0.134** 0.003 -0.345** -0.143* 0.046 0.016 -0.056 0.011 -0.052 -0.107**
OCP 0.217** -0.162** 0.431 ** 0.109 -0.014 -0.003 -0.008 0.081* 0.049 0.232**
AI 0.078* -0.059 -0.055 -0.180** 0.123** 0.126** 0.058 0.093** 0.081* 0.013
Smoking -0.016 0.079* -0.166** -0.124* 0.076* 0.129** 0.097** 0.018 0.026 -0.119**
AlI 0.001 0.066* -0.125** -0.098 0.104** 0.134** 0.119** -0.015 0.066* -0.073*
PIA 0.045 -0.092** 0.120** -0.124* -0.031 -0.089** -0.148** 0.070* -0.070* 0.148**
Variables (continued) TG LDL-c HDL-c EH EDU OCP AI Smoking AlI PIA
SBP 0.021 0.058** -0.117** 0.056** -0.124** 0.173** -0.005 0.008 0.042* -0.027
DBP 0.446** 0.051** 0.017 -0.045* -0.214** -0.005 -0.070** 0.035 -0.005 -0.009
FBS 0.068** 0.055** -0.400** 0.108** -0.264** 0.305** 0.070** 0.025 0.029 0.041*
HbA1c 0.073 0.082* -0.008 0.158** -0.154** 0.065 -0.071 -0.033 -0.001 -0.103**
BMI 0.081** 0.117** -0.186** 0.018 -0.042* 0.061** 0.062** 0.066** 0.075** 0.004
WC 0.009 0.112** -0.250** 0.048** -0.036 0.091** 0.088** 0.182** 0.176** 0.003
HC 0.270** 0.139** -0.140** 0.053** -0.204** 0.125** -0.027 0.062** 0.031 0.009
WHR -0.248** -0.033 -0.114** 0.029 0.116** -0.011 0.102** 0.102** 0.122** -0.009
WHtR 0 0.117** -0.185** 0.033 -0.065** 0.131** 0.051** 0.071** 0.076** 0.009
TC -0.237** 0.530** 0.007 0.092** 0.164** 0.024 0.116** 0.041* 0.103** 0
TG 1 0.219** -0.169** -0.053** -0.176** -0.068** -0.045* 0.167** 0.086** -0.011
LDL-c 0.249** 1 0.060** 0.016 -0.002 -0.009 0.027 0.054** 0.076** 0.004
HDL-c -0.03 0.196** 1 -0.079** 0.177** -0.157** -0.069** -0.191** -0.162** -0.002
EH -0.032 -0.015 -0.102** 1 -0.022 0.008 0.096** 0.049** 0.063** 0.071**
EDU 0.063 -0.012 0.182** -0.094** 1 -0.341** 0.211** 0.027 0.077** -0.052**
OCP -0.205** -0.019 -0.186** 0.016 -0.501** 1 -0.171** -0.128** -0.120** 0.032
AI -0.029 0.002 -i0.074* -0.036 0.336** -0.241** 1 0.078** 0.129** 0.042*
Smoking 0.182** 0.04 -0.049 0.007 0.233** -0.261** 0.134** 1 0.535** -0.011
AlI 0.157** 0.029 -0.065 -0.004 0.195** -0.236** 0.163** 0.506** 1 -0.062**
PIA -0.139** -0.027 -0.048 -0.034 -0.047 0.06 0.06 -0.088** -0.105** 1

** Correlation is significant at the 0.01 level (2-tailed).

* Correlation is significant at the 0.05 level (2-tailed).

Abbreviations: SBP: Systolic Blood Pressure, DBP: Diastolic Blood Pressure, FBS: Fasting Blood Sugar, WC: Waist Circumference, HC: Hip Circumference, WHR: Waist-to-Hip Ratio, WHtR: Waist-to-Height Ratio, TC: Total Cholesterol, TG: Triglycerides, LDL-c: Low Density Lipoprotein cholesterol, HDL-c: High Density Lipoprotein cholesterol, EH: Eating Habits, EDU: Education. OCP: Occupation, AI: Average income, AlI: Alcohol intake, PIA: Physical inactivity.

Diabetic population characteristics

In Table 5, A total of 1507 diabetic patients (513 rural participants and 994 urban participants) were enrolled with a media age of 53.7 years (IQR, 46.2–61.4). With respect to age distribution (p = 0.011), occupation (p < 0.001), level of education (p < 0.001), average income (p < 0.001), physical inactivity (p < 0.001), smoking (p = 0.003), alcohol intake (p < 0.001), and eating habits (p = 0.042), significant differences were observed between urban and rural participants. There were no significant differences regarding gender distribution (p = 0.239), marital status (p = 0.908), intensity of performed physical activity (p = 0.287) and reached recommended amount of fruits and vegetables/day (p = 0.179).

Table 5. Socio-demographic characteristics of the diabetes population in urban and rural areas, median (IQR) or n (%).

Variables Total (n = 1507) Rural (n = 513) Urban (n = 994) p-value
Age (years)
Median (IQR) 53.7 (46.2–61.4) 54.0 (46.2–62.0) 53.3 (46.2–61.0) 0.906
20–29 yrs n (%) 25 (1.7) 16 (3.1) 9 (0.9)
30–39 yrs n (%) 97 (6.4) 37 (7.2) 60 (6.0)
40–49 yrs n (%) 412 (27.3) 128 (25.0) 284 (28.6)
50–59 yrs n (%) 524 (34.8) 173 (33.7) 351 (35.3)
60+ yrs n (%) 449 (29.8) 159 (31.0) 290 (29.2) 0.011
Gender n (%)
Male 924 (61.3) 304 (59.3) 620 (62.4)
Female 583 (38.7) 209 (40.7) 374 (37.6) 0.239
Familly history of diabetes n (%)
No 1037 (68.6) 392 (76.4) 645 (64.9)
Yes 470 (31.2) 121 (23.6) 349 (35.1) < 0.001
Marital status n (%)
Single 56 (3.7) 17 (3.3) 39 (3.9)
Married 1396 (92.6) 476 (92.8) 920 (92.6)
Divorced 18 (1.2) 7 (1.4) 11 (1.1)
Widowed 37 (2.5) 13 (2.5) 24 (2.4) 0.908
Occupation n (%)
Formal 679 (45.2) 136 (26.7) 543 (54.7)
Informal 281 (18.7) 189 (37.1) 92 (9.3)
Unemployed 541 (36.0) 184 (36.1) 357 (36.0) < 0.001
Level of education n (%)
Illiterate 67 (4.5) 46 (9.0) 21 (2.1)
Basic 246 (16.4) 136 (26.7) 110 (11.1)
Secondary education 641 (42.7) 237 (46.6) 404 (40.7)
Tertiary 548 (36.5) 90 (17.7) 458 (46.1) < 0.001
Average income (RMB) n (%)
<2000 307 (20.4) 172 (33.8) 135 (13.6)
2000~4000 951 (56.7) 290 (57.0) 561 (56.5)
4000~6000 256 (17.0) 33 (6.5) 223 (22.5)
6000~8000 65 (4.3) 11 (2.2) 54 (5.4)
≥8000 23 (1.5) 3 (0.6) 20 (2.0) < 0.001
Smoking n (%)
No 1070 (71.1) 390 (76.0) 680 (68.6)
Yes 434 (28.9) 123 (24.0) 311 (31.4) 0.003
Alcohol intake n (%)
No 1183 (78.6) 437 (85.2) 746 (75.2)
Yes 322 (21.4) 76 (14.8) 246 (24.8) < 0.001
Physical activity on regular basis
No 980 (65.0) 373 (72.7) 607 (61.1)
Yes 527 (35.0) 140 (27.3) 387 (38.9) < 0.001
Intensity of performed physical activity
High 31 (5.9) 12 (8.6) 19 (4.9)
Moderate 42 (8.0) 11 (7.9) 31 (8.0)
Low 454 (86.1) 117 (83.6) 337 (87.1) 0.287
Eating habits
3 main courses/day 1158 (76.8) 410 (79.9) 748 (75.3)
Irregular habits 349 (23.2) 103 (20.1) 246 (24.7) 0.042
Reached recommended amount of fruits and vegetables/day
No 489 (32.5) 155 (30.3) 334 (33.7)
Yes 1014 (67.5) 357 (69.7) 657 (66.3) 0.179

Data is presented as median (IQR) or n (%); Chi-square or Fisher’s test. p < 0.05 was considered significant difference. n: number. Physical activity on regular basis: Only participants reporting regular physical activity included in this analysis, ≥ 5 times/week at moderate or high intensity, Reached recommended amount of fruits and vegetables/day: 500 grams of fruits and vegetables/day.

Metabolic risk factors for T2DM

Anthropometric variables and serum lipid levels of diabetes population between urban and rural areas are compared in Table 6. Significant differences in weight (p < 0.001), BMI (p = 0.016) and HDL-c (p < 0.001) were observed between participants of urban and rural areas. There were no significant differences with respect to systolic (p = 0.264) and diastolic BP (p = 0.429), total cholesterol (p = 0.790), triglycerides (p = 0.565), and LDL-c (p = 0.106) [Table 6].

Table 6. Anthropometric variables and serum lipid levels comparison of the diabetes population, median (IQR) or n (%).

Variables Total (n = 1507) Rural (n = 513) Urban (n = 994) p-value
SBP (mmHg) 116.5 (123–138) 125 (115–140) 121 (116.88–135) 0.264
DBP (mmHg) 70 (80–85) 80 (70–85) 80 (70–80.62) 0.429
Hypertention 475(31.5) 171(33.3) 304(30.6) 0.276
Weight (Kg) 69 (78–86) 76 (66–85) 80 (70–87.00) <0.001
Height (m) 1.63 (1.69–1.73) 1.68 (1.62–1.73) 1.69 (1.64–1.74) 0.029
BMI (Kg/m2) 24.77 (27.37–29.98) 26.99 (24.05–30.00) 27.53 (25.09–29.94) 0.016
Obesity (BMI ≥ 28 Kg/m2) 648(43.1) 200(39.0) 448(45.3) 0.020
WC(cm) 69 (78–86) 98 (89.25–105.75) 99 (90–105) 0.099
HC (cm) 95 (102–110) 102 (93–110) 103 (95–109) 0.815
WHR 90 (99–105) 0.95 (0.91–1.03) 0.96 (0.91–1.04) 0.052
TC (mmol/l) median (IQR) 3.76 (4.48–5.23) 4.51 (3.73–5.20) 4.47 (3.77–5.24) 0.790
TG(mmol/l) median (IQR) 1.24 (1.79–2.65) 1.81 (1.23–2.62) 1.79 (1.25–2.66) 0.565
HDL-c (mmol/l) median (IQR) 0.77 (0.92–1.11) 0.87 (0.72–1.06) 0.95 (0.79–1.15) <0.001
LDL-c (mmol/l) median (IQR) 2.23 (2.77–3.38) 2.74 (2.12–3.32) 2.78 (2.29–3.41) 0.106

Glucose control and complications of the diabetic population

At least one chronic complication was diagnosed in 74.0% participants. Most patients had poor glycemic control (HbA1c >8%, 52.4%). Participants in the rural area were significantly more likely to have better glycemic control (p = 0.019) and tend to have less diabetes-related complications but no significant difference (72.2% versus 74.9%, p = 0.263). There was statistically significant difference in number of diabetes medications between rural and urban participants (p = 0.012), so was with the use of diabetes medications including biguanide, DPP4 inhibitor and glinides (p = 0.002, 0.004 and 0.024 respectively). Compared to rural participants, urban participants tended to develop large artery atherosclerosis, retinopathy and neuropathy (p = 0.035, 0.032 and 0.025 respectively) [Table 7].

Table 7. Blood glucose and complications of the diabetes population in this study, median (IQR) or n (%).

Variables Total (n = 1507) Rural (n = 513) Urban (n = 994) p-value
FBS (mmol/l) 8.51 (6.94–10.90) 8.55 (6.92–11.20) 8.45 (6.96–10.78) 0.554
FBS (> 7mmol/l) 1106 (73.6) 376 (73.3) 730 (73.7) 0.853
HbA1c (%) 8.00 (6.80–9.30) 7.90 (6.83–9.30) 8.00 (6.80–9.30) 0.900
HbA1c (> 7%) 968 (69.6) 356 (71.5) 612 (68.6) 0.263
HbA1c (> 8%) 789 (52.4) 247 (48.1) 542 (54.5) 0.019
HbA1c (> 9%) 406 (26.9) 141 (27.5) 265 (26.7) 0.732
Diabetes Medications
None 495 (35.5) 203 (40.8) 292 (32.6)
1 353 (25.3) 122 (24.5) 231 (25.8)
2 366 (26.2) 120 (24.1) 246 (27.4)
≥ 3 181 (13.0) 53 (10.6) 128 (14.3) 0.012
Biguanide 617 (44.0) 192 (38.6) 425 (47.0) 0.002
Sulfonylurea 88 (6.3) 24 (4.8) 64 (7.1) 0.088
Thiazolidenedione 10 (0.7) 1 (0.2) 9 (1.0) 0.089
Alpha glucosidase inhibitor 148 (10.6) 48 (9.6) 100 (11.1) 0.384
DPP4 inhibitor 41 (2.9) 6 (1.2) 35 (3.9) 0.004
Insulin 630 (44.6) 220 (43.8) 410 (45.1) 0.643
Exenatide or Liraglutide 7 (0.5) 1 (0.2) 6 (0.7) 0.236
Glinides 134 (9.6) 36 (7.2) 98 (10.9) 0.024
Diabetes-related complications n (%)
None 363 (26.0) 138 (27.8) 225 (25.1)
Yes 1031 (74.0) 359 (72.2) 672 (74.9)
1 404 (29.1) 148 (29.8) 256 (28.5)
2 285 (20.4) 104 (20.9) 181 (20.2)
≥3 342 (24.5) 107 (21.5) 235 (26.2) 0.263
Macrovascular complications
CAD 469 (33.4) 156 (31.3) 313 (34.5) 0.221
Stroke/TIA 156 (11.2) 63 (12.7) 93 (10.4) 0.192
Large artery atherosclerosis 539 (38.6) 174 (34.9) 365 (40.7) 0.035
Microvascular complications
Retinopathy 353 (25.2) 109 (21.9) 244 (27.1) 0.032
Nephropathy 98 (7.0) 31 (6.2) 67 (7.5) 0.384
Neuropathy 540 (38.7) 173 (34.7) 367 (40.8) 0.025
DFD 21 (1.5) 11 (2.2) 10 (1.1) 0.108

Data is presented as median (IQR) or n (%); Chi-square or Fisher’s test. p < 0.05 was considered significant difference. n: number, DFD: Diabetic Foot Disease.

Metabolic risk factors for glucose control and complications

We compared selected metabolic risk factors by the presence of diabetic complications and settlements (rural or urban). In the rural diabetics, those with diabetic complications had higher prevalence of FBS (> 7mmol/l), HbA1c (> 9%), obesity, triglycerides (≥ 1.71mmol/l) and irregular eating habits compared to those with non-diabetics. In the urban diabetics, there were significant differences regarding metabolic risk factors including FBS (>7mmol/l), obesity, HbA1c (>9%) and irregular eating habits [Table 8].

Table 8. Characteristics of patients with diabetes, according to presence or absence of complications and area.

Variables Rural diabetics Urban diabetics
Diabetic complications Diabetic complications
Total (n = 513) No (n = 138) Yes (n = 375) p-value Total (n = 994 No (n = 255) Yes (n = 739) p-value
FBS (> 7mmol/l) 365 (73.4) 90 (65.2) 275 (76.6) 0.01 664 (74.1) 151 (67.1) 513 (76.5) 0.006
HbA1c(> 7%) 355 (71.4) 106 (76.8) 249 (69.4) 0.1 612 (68.6) 142 (64.3) 470 (70.0) 0.108
HbA1c(> 8%) 232 (46.7) 58 (42.0) 249 (48.5) 0.198 445 (49.6) 104 (46.2) 341 (50.7) 0.24
HbA1c(> 9%) 141 (28.4) 23 (16.7) 249 (32.9) < 0.001 265 (29.5) 48 (21.3) 217 (32.3) 0.002
Overweight (BMI ≥ 25 Kg/m2) 147 (48.5) 46 (46.5) 101 (49.5) 0.619 259 (53.8) 72 (53.3) 187 (54.0) 0.888
Obesity (BMI ≥ 28 Kg/m2) 194 (55.4) 39 (42.4) 155 (60.1) 0.003 412 (65.0) 86 (57.7) 326 (67.2) 0.034
TC(≥ 5.20 mmol/l) 124 (25.0) 30 (21.7) 94 (26.3) 0.298 238 (26.6) 56 (24.9) 182 (27.1) 0.511
TG (≥ 1.71mmol/l) 261 (52.6) 54 (39.1) 207 (57.8) < 0.001 463 (51.7) 107 (47.6) 356 (53.1) 0.153
HDL-c (< 1.04 mmol/l) 362 (73.0) 95 (68.8) 267 (74.6) 0.197 578 (64.5) 139 (61.8) 439 (65.4) 0.322
LDL-c (≥ 3.38 mmol/l) 113 (22.8) 30 (21.7) 83 (23.2) 0.731 237 (26.5) 53 (23.6) 184 (27.4) 0.255
Irregular eating habits 102 (20.5) 20 (14.5) 82 (22.8) 0.039 239 (26.6) 47 (20.9) 192 (28.6) 0.024

Data is presented as n(%); Chi-square or Fisher’s test. p < 0.05 was considered significant difference. BMI: Body Mass Index, TC: Total Cholesterol, TG: Triglycerides, HDL-c: High Density Lipoprotein cholesterol, LDL-c: Low Density Lipoprotein cholesterol.

After adjusting for gender and age, differences in some risk factors between rural and urban diabetic participants remained significant. Urban participants were more likely to have risk factors of diabetic complications including obesity, HDL-c (< 1.04 mmol/l), physical inactivity and irregular eating habits [Table 9].

Table 9. Multivariable association of diabetic complication control with selected risk factors (reference: rural population).

Risk factors OR (95% CI) p- value Adj. OR-gender (95% CI) p- value Adj. OR-gender and age (95% CI) p- value
FBS (> 7mmol/l) 1.148(0.883–1.491) 0.303 1.136(0.874–1.477) 0.341 1.139(0.876–1.482) 0.330
HbA1c (> 7%) 0.800(0.622–1.030) 0.083 0.801(0.622–1.031) 0.086 0.798(0.620–1.028) 0.080
Overweight (BMI25 Kg/m2) 1.187(0.878–1.605) 0.265 1.165(0.860–1.578) 0.325 1.160(0.855–1.572) 0.340
Obesity (≥ 28 Kg/m2) 1.384(1.034–1.852) 0.029 1.370(1.023–1.834) 0.035 1.369(1.022–1.833) 0.035
WC (men ≥ 90 cm; women ≥ 85 cm) 1.323(0.952–1.838) 0.096 1.316(0.947–1.831) 0.102 1.318(0.948–1.833) 0.101
WHR (men > 0.90; women > 0.85) 1.006(0.683–1.482) 0.976 1.039(0.702–1.537) 0.849 1.037(0.701–1.535) 0.854
Total cholesterol (≥ 5.20 mmol/l) 0.846(0.574–1.249) 0.400 0.853(0.578–1.259) 0.424 0.855(0.579–1.261) 0.429
Triglycerides (≥ 1.71mmol/l) 0.983(0.772–1.252) 0.890 0.984(0.772–1.253) 0.893 0.985(0.773–1.255) 0.903
HDL-c (< 1.04 mmol/l) 0.668(0.518–0.862) 0.002 0.648(0.499–0.840) 0.001 0.648(0.499–0.841) 0.001
LDL-c (≥ 3.38 mmol/l) 1.264(0.858–1.864) 0.236 1.266(0.858–1.867) 0.235 1.259(0.854–1.857) 0.245
Physical inactivity 0.615(0.481–0.788) <0.001 0.616(0.481–0.788) <0.001 0.619(0.483–0.793) <0.001
Irregular eating habits 1.410(1.077–1.846) 0.012 1.400(1.069–1.834) 0.014 1.412(1.077–1.851) 0.013

OR: Odds ratio. Adj: adjusted. Compared using multivariate logistic regression. p < 0.05 was considered significant difference.

Discussion

With the urbanization, the burden of non-communicable diseases such as T2DM is being increased. While the prevalence of diabetes rising across all over the world, a higher growing trend was observed in developing countries, especially in rural areas. The global rural prevalence of diabetes was 5.7% (3.5–7.9) during 1985–1989 and 8.7% (6.8–10.7) during 2005–2011 [13]. In 2009, the prevalence of diagnosed T2DM in rural adults in Shanghai, China increased from 6.1% in 2002–2003 to 9.8% in 2009 [20]. Prevalence of diabetes is driven primarily by accompanying metabolic risk factors such as smoking, physical inactivity, overweight or obesity, dyslipidaemia, uric acid and harmful alcohol intake [3843].

In this study, differences between participants residing in urban and rural settlements as for metabolic risk factors were described, as well as glycemic control and complications in diabetic participants enrolled in both areas. It is however noteworthy that along with the observed differences in prevalence of type 2 diabetes prediabetes and metabolic risk factors including hypertension and hyperlipidemia, we recorded more male subjects in the rural community and more females in the urban community. Indices of overweight and obesity (BMI and WHR) were observed higher in urban residents, as previous studies had shown [11,44,45]. At the time of survey, urban participants were still heavily impacted by unhealthy lifestyles involving physical inactivity and alcohol intake excessively although they had higher literacy, more employment and income. The higher prevalence of being overweight and/or obesity in urban residents might be ascribed to unhealthy lifestyles including physical inactivity and harmful alcohol intake.

Compared to urban residents, rural residents had higher concentration of LDL-c, and lower concentration of HDL-c. The differences of dyslipidaemia were confirmed to be significant different metabolic risk factors between urban and rural areas including HDL-c (< 1.04 mmol/l) and triglycerides (≥1.71mmol/l). Previous studies on the difference of HDL-c between urban and rural residents remained controversial [35, 38, 40, 4244]. In this study, significant difference of the HDL-c was confirmed. It is noteworthy that among all participants, amounting to 38.8% had low HDL cholesterol.

Overweight, obesity and physical inactivity are important risk factors for diverse chronic medical conditions, including hypertension, dyslipidaemia and diabetes. In this study [3,4,44], we confirmed positive correlations between anthropometric variables, and serum lipids and blood pressure in both areas studied. Diabetic participants of urban residents in this study appeared to be less healthy than those enrolled in rural residents. The results showed that the median HbA1c level among diabetics in both regions was high, with no difference between rural and urban areas. And 69.6% of these subjects had bad control of diabetes as defined as HbA1c level > 7%. In urban area, more than 54.5% of their diabetic patients had poorly controlled diabetes as defined as HbA1c level ≥ 8%, while so was 48.1% of their patients in rural area, and similar results were found in Wuxi city, China [46]. Compared to rural diabetic participants, the urban diabetic participants had a higher prevalence of smoking, alcohol intake, physical inactivity, dyslipidaemia and irregular eating habits. Other predictors of glycemic control in terms of gender, history of hypertension and intensity of performed physical activity, there were no statistically significant differences between rural and urban diabetic participants. It is noteworthy that urban residents had better socioeconomic status as indicators of education, income and occupation were significantly better than rural residents. Recent studies showed that knowledge and awareness about diabetes in rural areas were poor and these may contribute to poor glycemic control for rural residents [47]. And future work will focus on the level of awareness and knowledge of diabetes in the general population as well as diabetic subjects in Xinjiang, China.

The prevalence of T2DM of urban residents wase found, in most studies, significantly higher than that of rural residents [20,39,48], while little literacy focused on the prevalence of the total diabetic complications. In this study, 74.0% of the T2DM registered were suffering from at least one diabetic chronic complication. And out of expect, no significant difference regarding the prevalence of T2DM complications in urban participants and rural participants was detected (72.2% versus 74.9%, P = 0.263).

It was apparent that poor glycemic control (HbA1c>9%), obesity and dyslipidaemia were contributing factors for the diabetic complications as found in this study. There were significant differences with respect to FBS (>7mmol/l), HbA1c (>9%), HDL-c (< 1.04 mmol/l) and irregular eating habits amongst participants with no diabetic complications and those combined with diabetic complications in both urban and rural areas.

Xinjiang Uygur Autonomous Region is located in the northwest of China and composed of more than 13 ethnic groups. The population density of was 4.42‰, and Uygur account for 46%, Han account for 40%, and Kazak account for 7%. The rural population of Xinjiang amounts to12.04 million with per capita disposable income of 5442 RMB [28]. Most rural residents were of low socioeconomic status and acquired little health knowledge awareness, as indicated in this study, and need long distance to the nearest medical institutions [28]. And this may contribute to the prevalence of diabetic complications.

It was highlighted by previous studies [10,49] that obesity was a major risk factor for prevalence of T2DM and glycemic control, so the diabetic complications were expected to be higher prevalence among obese participants. With the expectation, we found a higher prevalence obesity in urban and rural diabetic participants with complications. And these findings confirm that obesity is a major/traditional contributor to complications of T2DM in urban and rural areas.

Limitations

Several limitations deserve to be mentioned. First, cross-sectional nature of this study determines that all participants in both urban and rural areas are not followed up, thus we don’t know the impact of changes in lifestyle on the epidemic of diabetes and the related complications threatens. Second, current study may not necessarily reflect the true prevalence of T2DM and related complications at a province or national level, since participants were recruited only in the First Affiliated Hospital of Xinjiang Medical University. Third, information of participants were obtained from patient medical records or via participant self-report, thus, results might be adversely affected by recall bias or social desirability bias. Finally, uric aicd is considered as an important metabloic risk factor and Ivonne Sluijs et al., [43] showed that higher uric acid was associated with a higher diabetes risk. The prevalence of hyperuricemia in Uygur subjects in Xinjiang was 8.2% [50]. The confirmation of the correlation between serum uric acid level and a variety of metabolic parameter however was not designed in this study, although this was supported by our previous study [50].

Conclusions

In summary, the present study provides a snapshot of the current situation of metabolic risk factors and complications of T2DM in both urban and rural communities in Xinjiang, China. There is an urgent need to avert the unhealthy lifestyle, and those people with high risk factors are recommended keeping healthy normal weight and developing a physically active lifestyle. There is an urgent need to increase awareness for approaches for the prevention and better management of T2DM and its complications with urbanization especially in developing countries.

Acknowledgments

The authors would like to thank all members of the household survey study group who voluntarily contributed to the acquisition of data in this study.

Data Availability

All relevant data are within the paper.

Funding Statement

The survey was funded by the National Basic Research Program of China (973 program) (2012CB722403). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Association AD. STANDARDS OF MEDICAL CARE IN DIABETES—2015. Diabetes Care. 2015; 38; supplement 1: S1–93. [Google Scholar]
  • 2.Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. The Lancet. 2011; 378: 31–40, 10.1016/s0140-6736(11)60679-x . [DOI] [PubMed] [Google Scholar]
  • 3.Yoon K-H, Lee J-H, Kim J-W, Cho JH, Choi Y-H, Ko S-H, et al. Epidemic obesity and type 2 diabetes in Asia. The Lancet. 2006; 368: 1681–1688, 10.1016/s0140-6736(06)69703-1 . [DOI] [PubMed] [Google Scholar]
  • 4.Lee HY, Won JC, Kang YJ, Yoon SH, Choi EO, Bae JY, et al. Type 2 diabetes in urban and rural districts in Korea: factors associated with prevalence difference. J Korean Med Sci. 2010; 25: 1777–1783, 10.3346/jkms.2010.25.12.1777 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Zhenfang XIA, Zhuanshuo W, Qunfang CAI, Jianjun YANG, Xuan ZHANG, Tubao YANG. Prevalence and Risk Factors of Type 2 Diabetes in the Adults in Haikou City, Hainan Island, China. Iranian J Publ Health. 2013; 42(3): 222–230, . [PMC free article] [PubMed] [Google Scholar]
  • 6.Sodjinou R, Agueh V, Fayomi B, Delisle H. Obesity and cardio-metabolic risk factors in urban adults of Benin: relationship with socio-economic status, urbanisation, and lifestyle patterns. BMC Public Health. 2008; 8: 84, 10.1186/1471-2458-8-84 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Weng X LY, Ma J, Wang W, Yang G, Caballero B. An urban-rural comparison of the prevalence of the metabolic syndrome in Eastern China . Public Health Nutrition. 2007; 10(2): 131–6, 10.1017/S1368980007226023 . [DOI] [PubMed] [Google Scholar]
  • 8.Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014; 103: 137–149, 10.1016/j.diabres.2013.11.002 . [DOI] [PubMed] [Google Scholar]
  • 9.Ramachandran A, Mary S, Yamuna A, Murugesan N, Snehalatha C. High prevalence of diabetes and cardiovascular risk factors associated with urbanization in India. Diabetes Care. 2008; 31: 893–898, 10.2337/dc07-1207 . [DOI] [PubMed] [Google Scholar]
  • 10.Khan AR, Al Abdul Lateef ZN, Fatima S, Al Yousuf SA, Khan Afghan SZ, Al Marghani S. Prevalence of chronic complication among type 2 diabetics attending primary health care centers of Al Ahsa district of Saudi Arabia: a cross sectional survey. Glob J Health Sci. 2014; 6: 245–253, 10.5539/gjhs.v6n4p245 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Ebrahim S, Kinra S, Bowen L, Andersen E, Ben-Shlomo Y, Lyngdoh T, et al. The effect of rural-to-urban migration on obesity and diabetes in India: a cross-sectional study. PLoS Med. 2010; 7: e1000268, 10.1371/journal.pmed.1000268 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010; 87: 4–14, 10.1016/j.diabres.2009.10.007 . [DOI] [PubMed] [Google Scholar]
  • 13.Zabetian A, Sanchez IM, Narayan KM, Hwang CK, Ali MK. Global rural diabetes prevalence: a systematic review and meta-analysis covering 1990–2012. Diabetes Res Clin Pract. 2014; 104: 206–213, 10.1016/j.diabres.2014.01.005 . [DOI] [PubMed] [Google Scholar]
  • 14.Gharbi M, Akrout M, Zouari B. Prevalence and risk factors of non-insulin-dependent diabetes mellitus in the rural and urban population of Tunisia. Rev Epidemiol Sante Publique. 2002; 50: 349–355, . [PubMed] [Google Scholar]
  • 15.Mwanri AW, Kinabo J, Ramaiya K, Feskens EJ. Prevalence of gestational diabetes mellitus in urban and rural Tanzania. Diabetes Res Clin Pract. 2014; 103: 71–78, 10.1016/j.diabres.2013.11.021 . [DOI] [PubMed] [Google Scholar]
  • 16.Le C, Lin L, Jun D, Jianhui H, Keying Z, Wenlong C, et al. The economic burden of type 2 diabetes mellitus in rural southwest China. Int J Cardiol. 2013; 165: 273–277, 10.1016/j.ijcard.2011.08.039 . [DOI] [PubMed] [Google Scholar]
  • 17.Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, et al. Prevalence of diabetes among men and women in China. N Engl J Med. 2010; 362: 1090–1101, 10.1056/NEJMoa0908292 . [DOI] [PubMed] [Google Scholar]
  • 18.Xu Y, Wang L, He J, Bi Y, Li M, Wang T, et al. Prevalence and control of diabetes in Chinese adults. Jama. 2013; 310: 948–959, 10.1001/jama.2013.168118 . [DOI] [PubMed] [Google Scholar]
  • 19.Chinese Diabetes Society. China Guideline for Type 2 Diabetes Mellitus (2013 Edition). Chinese Journal of Endocrinology and Metabolism. 2014; 30(10): 893–943. [Google Scholar]
  • 20.Li R, Lu W, Jiang QW, Li YY, Zhao GM, Shi L, et al. Increasing prevalence of type 2 diabetes in Chinese adults in Shanghai. Diabetes Care. 2012; 35: 1028–1030, 10.2337/dc11-1212 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Motala AA. Diabetes trends in Africa. Diabetes Metab Res Rev. 2002; 18 Suppl 3: S14–20, 10.1002/dmrr.284 . [DOI] [PubMed] [Google Scholar]
  • 22.Gao WG, Dong YH, Pang ZC, Nan HR, Zhang L, Wang SJ, et al. Increasing trend in the prevalence of Type 2 diabetes and pre-diabetes in the Chinese rural and urban population in Qingdao, China. Diabet Med. 2009; 26: 1220–1227, 10.1111/j.1464-5491.2009.02832.x . [DOI] [PubMed] [Google Scholar]
  • 23.Hwang CK, Han PV, Zabetian A, Ali MK, Narayan KM. Rural diabetes prevalence quintuples over twenty-five years in low- and middle-income countries: a systematic review and meta-analysis. Diabetes Res Clin Pract. 2012; 96: 271–285, 10.1016/j.diabres.2011.12.001 . [DOI] [PubMed] [Google Scholar]
  • 24.Lynch CP, Strom JL, Egede LE. Disparities in diabetes self-management and quality of care in rural versus urban veterans. J Diabetes Complications. 2011; 25: 387–392, 10.1016/j.jdiacomp.2011.08.003 . [DOI] [PubMed] [Google Scholar]
  • 25.Yang YN, Xie X, Ma YT, Li XM, Fu ZY, Ma X, et al. Type 2 diabetes in Xinjiang Uygur autonomous region, China. PLoS One. 2012; 7: e35270, 10.1371/journal.pone.0035270 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Yao H, Wang Z, Wang T, Ma Y, Su Y, Ma Q, et al. Association of TCF7L2 Genetic Polymorphisms with Type 2 Diabetes Mellitus in the Uygur Population of China. Int J Environ Res Public Health. 2015; 12: 11797–11814, 10.3390/ijerph120911797 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Li LL, Ma XL, Ran JX, Sun XF, Xu LM, Ren J, et al. Genetic polymorphism of peroxisome proliferator-activated receptor-gamma 2 Pro12Ala on ethnic susceptibility to diabetes in Uygur, Kazak and Han subjects. Clin Exp Pharmacol Physiol. 2008; 35: 187–191, 10.1111/j.1440-1681.2007.04796.x . [DOI] [PubMed] [Google Scholar]
  • 28.Yuan F, Qian D, Huang C, Tian M, Xiang Y, He Z, et al. Analysis of awareness of health knowledge among rural residents in Western China. BMC Public Health. 2015; 15: 55, 10.1186/s12889-015-1393-2 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Després JP, Lemieux I, Prud'homme D. Treatment of obesity: need to focus on high risk abdominally obese patients. BMJ. 2001; 322: 716–720, . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Kirkendall WM, Burton AC, Epstein FH, Freis ED. Recommendations for human blood pressure determination by sphygmomanometers. Circulation. 1967; 36: 980–988, . [DOI] [PubMed] [Google Scholar]
  • 31.Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO Consultation, Part1: Diagnosis and Classification of Diabetes Mellitus, Geneva 1999, World Health Organization. Available: http://apps.who.int/iris/bitstream/10665/66040/1/WHO_NCD_NCS_99.2.pdf.
  • 32.Fihn SD, Blankenship JC, Alexander KP, Bittl JA, Byrne JG, Fletcher BJ, et al. 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2014; 64: 1929–1949, 10.1016/j.jacc.2014.07.017 . [DOI] [PubMed] [Google Scholar]
  • 33.Avogaro A, Giorda C, Maggini M, Mannucci E, Raschetti R, Lombardo F, et al. Incidence of coronary heart disease in type 2 diabetic men and women: impact of microvascular complications, treatment, and geographic location. Diabetes Care. 2007; 30: 1241–1247, 10.2337/dc06-2558 . [DOI] [PubMed] [Google Scholar]
  • 34.Salvotelli L, Stoico V, Perrone F, Cacciatori V, Negri C, Brangani C, et al. Prevalence of neuropathy in type 2 diabetic patients and its association with other diabetes complications: The Verona Diabetic Foot Screening Program. J Diabetes Complications. 2015; 29: 1066–1070, 10.1016/j.jdiacomp.2015.06.014 . [DOI] [PubMed] [Google Scholar]
  • 35.Bakker K, Apelqvist J, Schaper NC. Practical guidelines on the management and prevention of the diabetic foot 2011. Diabetes Metab Res Rev. 2012; 28 Suppl 1: 225–231, 10.1002/dmrr.2253 . [DOI] [PubMed] [Google Scholar]
  • 36.KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. American Journal of Kidney Diseases. 2007; 49: S12–S154, 10.1053/j.ajkd.2006.12.005 . [DOI] [PubMed] [Google Scholar]
  • 37.KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update. Am J Kidney Dis. 2012; 60: 850–886, 10.1053/j.ajkd.2012.07.005 . [DOI] [PubMed] [Google Scholar]
  • 38.Sabir AA, Isezuo SA, Ohwovoriole AE, Fasanmade OA, Abubakar SA, Iwuala S, et al. Rural-urban difference in plasma lipid levels and prevalence of dyslipidemia in Hausa-Fulani of north-western Nigeria. Ethn Dis. 2013; 23: 374–378, . [PubMed] [Google Scholar]
  • 39.Zimmet P, Faaiuso S, Ainuu J, Whitehouse S, Milne B, DeBoer W. The prevalence of diabetes in the rural and urban Polynesian population of Western Samoa. Diabetes. 1981; 30: 45–51, . [DOI] [PubMed] [Google Scholar]
  • 40.Zaman F, Borang A. Prevalence of diabetes mellitus amongst rural hilly population of North Eastern India and its relationship with associated risk factors and related co-morbidities. Journal of Natural Science, Biology and Medicine. 2014; 5(2): 383–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Joshi SR, Anjana RM, Deepa M, Pradeepa R, Bhansali A, Dhandania VK, et al. Prevalence of dyslipidemia in urban and rural India: the ICMR-INDIAB study. PLoS One. 2014; 9: e96808, 10.1371/journal.pone.0096808 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Al-Nuaim AR. Prevalence of glucose intolerance in urban and rural communities in Saudi Arabia. Diabet Med. 1997; 14: 595–602, . [DOI] [PubMed] [Google Scholar]
  • 43.Sluijs I, Holmes MV, van der Schouw YT, Beulens JW, Asselbergs FW, Huerta JM, et al. A Mendelian Randomization Study of Circulating Uric Acid and Type 2 Diabetes. Diabetes. 2015;64: 3028–3036, 10.2337/db14-0742 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Obirikorang C, Osakunor DN, Anto EO, Amponsah SO, Adarkwa OK. Obesity and Cardio-Metabolic Risk Factors in an Urban and Rural Population in the Ashanti Region-Ghana: A Comparative Cross-Sectional Study. PLoS One. 2015; 10: e0129494, 10.1371/journal.pone.0129494 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Hendriks ME, Wit FW, Roos MT, Brewster LM, Akande TM, de Beer IH, et al. Hypertension in sub-Saharan Africa: cross-sectional surveys in four rural and urban communities. PLoS One. 2012; 7: e32638, 10.1371/journal.pone.0032638 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Mei-hua Dong, Yuan Qian, Jing-ping Zhang, En-qi He, Chong Shen, Jian Chen, et al. Status and its Influencing Factors of Blood Glucose Control in M anaged Diabetes in Urban and Rural Community of Wuxi city. Chin J Prey Contr Chron Dis. 2011; 19(6): 568–70. [Google Scholar]
  • 47.Deepa M, Bhansali A, Anjana RM, Pradeepa R, Joshi SR, Joshi PP, et al. Knowledge and awareness of diabetes in urban and rural India: The Indian Council of Medical Research India Diabetes Study (Phase I): Indian Council of Medical Research India Diabetes 4. Indian J Endocrinol Metab. 2014; 18: 379–385, 10.4103/2230-8210.131191 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Balasuriya B. M. A. C., Sumanatilleke M. R., Jayasekera T. I., et al. Prevalence of micro and macrovascular complications of diabetes detected at single visit screening. Sri Lanka Journal of Diabetes Endocrinology and Metabolism. 2012; 2(1): 17–20. [Google Scholar]
  • 49.Win Tin ST, Kenilorea G, Gadabu E, Tasserei J, Colagiuri R. The prevalence of diabetes complications and associated risk factors in Pacific Islands countries. Diabetes Res Clin Pract. 2014; 103: 114–118, 10.1016/j.diabres.2013.09.017 . [DOI] [PubMed] [Google Scholar]
  • 50.Wang Tingting MQ, Ma Yan, Zhang Bei, Su Yinxia, Wang Zhiqiang, Yao Hua. The relationship of serum uric acid with risk factors of metabolic syndrome in Uygur in Xinjiang. Chin J Endocrinol Metab. 2014;30: 5: 755–759. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

All relevant data are within the paper.


Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES